Five US states agree to sus­pend lit­i­ga­tion against bank­rupt opi­oid mak­er In­sys — re­port

While fil­ing for bank­rupt­cy last month, con­tro­ver­sial drug­mak­er In­sys sought an in­junc­tion against law­suits al­leg­ing the com­pa­ny stoked the opi­oid cri­sis. Five states have now re­port­ed­ly dropped their ob­jec­tions to that re­quest, and agreed to fa­cil­i­tate set­tle­ment talks.

In­sys’ $IN­SY bank­rupt­cy fil­ing came days af­ter the com­pa­ny agreed to pay $225 mil­lion to set­tle the US gov­ern­ment’s sep­a­rate crim­i­nal and civ­il in­ves­ti­ga­tions re­lat­ed to its spray, Sub­sys — about a month af­ter its founder and for­mer se­nior ex­ec­u­tive team were found guilty by a fed­er­al ju­ry of rack­e­teer­ing. Founder John Kapoor and his four com­pa­tri­ots’ an­tics in­clud­ed brib­ing doc­tors to pre­scribe the po­tent, ad­dic­tive painkiller and dup­ing in­sur­ers in­to pay­ing for the dead­ly opi­oid drug.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.